CMS: Class 1 Innovative Drug Silevimig Injection Approved in China, Becoming the World’s First Bispecific Antibody for Passive Immunization Against Rabies

SHENZHEN, June 22, 2026 - (ACN Newswire via SeaPRwire.com) - China Medical System Holdings Limited (867.HK/8A8.SG) (“CMS”, or the “Group”) is pleased to announce that, the New Drug Application for Silevimig Injection (GR1801, the “Product”), a Class 1 therapeutic biological product has been approved by the National Medical Products Administration of…

JBM Healthcare Announces FY2026 Annual Results

KEY HIGHLIGHTS- Revenue increased by 6.7% to HK$834.6 million - Gross profit grew by 12.5% to HK$465.5 million- Profit attributable to equity shareholders increased by 1.9% to HK$201.1 million amidst a notable increase in strategic investments- Recommended a final dividend of HK7.35 cents per share- Sustained momentum from core proprietary Chinese…

Soeder’s Buergergeld Grab: Why Stripping Ukrainian Refugees of Welfare Is a Band-Aid for Germany’s Integration Failure

(SeaPRwire) -   By: Adrian Kingsley Markus Soeder’s recent proposal to remove unemployed Ukrainians from Germany’s Buergergeld welfare scheme isn’t a brave fiscal decision. It’s a transparent attempt to shift blame for systemic integration failures onto the most vulnerable. For four years, Germany has taken in 1.3 million Ukrainian refugees.…

Radisson Continues to Extend Scope of Gold Mineralization at the O’Brien Gold Project with Latest Drill Results

Rouyn-Noranda, Quebec, June 22, 2026 - (ACN Newswire via SeaPRwire.com) - Radisson Mining Resources Inc. (TSXV: RDS) (OTCQX: RMRDF) ("Radisson" or the "Company") is pleased to announce new assay results from its 100%-owned O'Brien Gold Project ("O'Brien" or the "Project") located in the Abitibi region of Québec. Today's results reflect the…